Catalyst Wire Dossier Catalyst Wire Dossier

XIFYRM

meloxicam · Azurity Pharmaceuticals, Inc.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for XIFYRM, covering 2025-06-05 to 2025-06-05. Get the full timeline:

Most recent: FDA Approved: XIFYRM — Original Application (Azurity Pharmaceuticals, Inc.)

See pricing